Web13 nov. 2024 · Deals and Financings. Shanghai Zai Lab (NSDQ: ZLAB; HKEX: 9688) announced two major in-licensings: a $615 million deal for two cancer drugs from Blueprint Medicines and a $187 million agreement for a psychiatric drug from Karuna Therapeutics (NSDQ: KRTX) (see story).Zai will have greater China rights to two Blueprint next-gen … Web29 dec. 2024 · Ignis Therapeutics General Information. Description. Developer of innovative therapies in the field of central nervous system. The company is dedicated to the development of products to improve patients' lives, providing patients with more treatment options for clinical practice, and CNS innovative treatments.
Accuredit Therapeutics VentureRadar
Web16 nov. 2024 · Ignis Therapeutics co-launched by SK, 6 Dimensions with $180M series A Nov. 16, 2024 By Doris Yu and Gina Lee SK Biopharmaceuticals Co. Ltd. has launched a central nervous system-focused biotech company called Ignis Therapeutics Ltd. with a $180 million series A round led by 6 Dimensions Capital L.P. WebFounded in 1970, Jiangsu Hengrui Pharmaceuticals was originally state-owned and called Lianyungang Pharmaceutical Factory ( Chinese: 连云港制药厂 ). [4] [5] Headquartered in Lianyungang, Jiangsu, it was established in its current form in 1977. The company was listed on the Shanghai Stock Exchange in 2000 [6] and now has locations in China ... finishing edges of knitted blanket
A Global Fully Integrated Biotherapeutics Company - TRANSCENTA
WebIGNIS Therapeutics (Shanghai) Co., Ltd. Overview. Aiming at to be a global BIO pharmaceutical leader, deep rooted in China that develops and delivers innovative … Web16 nov. 2024 · SK Biopharmaceuticals Co. Ltd. has launched a central nervous system-focused biotech company called Ignis Therapeutics Ltd. with a $180 million series A … Web2024.01. NEUROPHTH THERAPEUTICS INC was founded in the U.S. 2024.04. Neurophth (Shanghai) Biological Technology Limited Company was founded. 2024.05. Neurophth (Suzhou) Biological Technology Limited Company was founded. 2024.08. Prof. Li’s team published the IIT1 clinical data of nearly 8 years’ follow-up in the journal of Ophthmology. … e-services firs